Inventor · Beijing, CN

Xiang Li

16Patents
2h-index
17Co-inventors
47Inventor score

Filing activity: Feb 10, 2005 → Oct 28, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US9546389B2 Methods and systems for nucleic acid amplification Emerging Cross-Sectional Technologies 5 Active
US7368258B1 Devices and methods for profiling enzyme substrates Physics 3 Active
US10465239B2 Methods and systems for nucleic acid amplification Emerging Cross-Sectional Technologies 1 Active
US10525047B2 PIM kinase inhibitors in combination with RNA splicing modulators/inhibitors for treatment of cancers Physics 1 Active
US12018278B2 Methods for chemically induced lineage reprogramming Chemistry; Metallurgy 0 Active
US10857185B2 Compositions and methods for reprogramming non-neuronal cells into neuron-like cells Chemistry; Metallurgy 0 Active
US11389440B2 PIM kinase inhibitors in combination with autophagy inhibitors for treatment of cancers Human Necessities 0 Active
US12016864B2 LOX enzyme inhibiting methods and compositions Chemistry; Metallurgy 0 Active
US11236089B2 Substituted pyrrolopyridines as ATR inhibitors Human Necessities 0 Active
US10208065B2 Crystalline free bases of C-Met inhibitor or crystalline acid salts thereof, and preparation methods and uses thereof Chemistry; Metallurgy 0 Active
US7951933B2 CD38 splice variants and uses thereof Human Necessities 0 Active
US7838268B2 Methods for modulating IKKα activity Physics 0 Active
US7666617B2 Devices and methods for profiling enzyme substrates Physics 0 Active
US11512111B2 Yeats inhibitors and methods of use thereof Human Necessities 0 Active
US8088915B2 Methods for modulating IKKα activity Physics 0 Active
US10842785B2 PIM kinase inhibitors in combination with RNA splicing modulators/inhibitors for treatment of cancers Physics 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.